In this study, the molecular mechanisms regulating CDC25C expression and subcellular location in HEY, BT-549, SKOv3 and MDA-MB-231cells before and after CoCl2 treatment were studied and the clinicopathological significance of CDC25C expression-related proteins were evaluated in human ovarian and breast cancer tissues. Here, CDC25C is linked to breast carcinoma.